A

Atossa Therapeutics
D

ATOS

0.85430
USD
0.00
(0.38%)
مغلق
حجم التداول
7,085
الربح لكل سهم
-0
العائد الربحي
-
P/E
-4
حجم السوق
110,349,934
أصول ذات صلة
A
AVXL
0.06000
(0.65%)
9.36000 USD
B
BKYI
0.01170
(1.48%)
0.80000 USD
D
DVAX
-0.145
(-1.26%)
11.330 USD
G
GNPX
0.00610
(2.20%)
0.28400 USD
I
IBIO
-0.02630
(-2.58%)
0.99370 USD
I
INO
0.03000
(1.59%)
1.91500 USD
N
NVAX
0.01000
(0.16%)
6.41000 USD
V
VXRT
0.01940
(4.52%)
0.44840 USD
المزيد
الأخبار المقالات

العنوان: Atossa Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.